Inhibikase Therapeutics Receives FDA Orphan Drug Designation

Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy

Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Denmark , United States , Georgia , Atlanta , Boston , Massachusetts , Copenhagen , Køavn , Miltonh Werner , Milton Werner , Alex Lobo , Linkedin , Sternir Inc , Nasdaq , Movement Disorder Society Congress , Youtube , Exchange Commission , Inhibikase Or Company , Drug Administration , Facebook , Company Contact , Inhibikase Therapeutics Inc , Drug Designation , Multiple System , Abelson Tyrosine Kinases , Orphan Drug Designation , Multiple System Atrophy , Chief Executive , System Atrophy , Abelson Tyrosine Kinase , Abelson Tyrosine , Private Securities Litigation Reform Act ,